BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong Y, Menon MC, Deng Y, Chen Y, He JC. Recent Advances in Traditional Chinese Medicine for Kidney Disease. Am J Kidney Dis 2015;66:513-22. [PMID: 26015275 DOI: 10.1053/j.ajkd.2015.04.013] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Lyu J, Xie Y, Sun M, Zhang L. Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment. Front Pharmacol 2020;11:822. [PMID: 32714181 DOI: 10.3389/fphar.2020.00822] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Seto SW, Kiat H, Lee SM, Bensoussan A, Sun YT, Hoi MP, Chang D. Zebrafish models of cardiovascular diseases and their applications in herbal medicine research. Eur J Pharmacol 2015;768:77-86. [PMID: 26494630 DOI: 10.1016/j.ejphar.2015.10.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Zhao M, Yu Y, Wang R, Chang M, Ma S, Qu H, Zhang Y. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease. Front Pharmacol 2020;11:619201. [PMID: 33854427 DOI: 10.3389/fphar.2020.619201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xi Y, Lu X, Zhu L, Sun X, Jiang Y, He W, Wei M. Clinical trial for conventional medicine integrated with traditional Chinese medicine (TCM) in the treatment of patients with chronic kidney disease. Medicine (Baltimore) 2020;99:e20234. [PMID: 32481298 DOI: 10.1097/MD.0000000000020234] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang XH, Lang R, Liang Y, Zeng Q, Chen N, Yu RH. Traditional Chinese Medicine in Treating IgA Nephropathy: From Basic Science to Clinical Research. J Transl Int Med 2021;9:161-7. [PMID: 34900626 DOI: 10.2478/jtim-2021-0021] [Reference Citation Analysis]
6 Han S, Yao T, Lu Y, Lu Y, Xu Y, Wang Y. Chinese Herbal Injections for Primary Nephrotic Syndrome in Adults: A Systematic Review and Network Meta-Analysis. Evid Based Complement Alternat Med 2020;2020:1047489. [PMID: 32184888 DOI: 10.1155/2020/1047489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xu H, Wu T, Huang L. Therapeutic and delivery strategies of phytoconstituents for renal fibrosis. Adv Drug Deliv Rev 2021;177:113911. [PMID: 34358538 DOI: 10.1016/j.addr.2021.113911] [Reference Citation Analysis]
8 Ding B, Ma G, Wang Z, Liang W, Gao W. Mechanisms of Kidney Cell Pyroptosis in Chronic Kidney Disease and the Effects of Traditional Chinese Medicine. Evid Based Complement Alternat Med 2021;2021:1173324. [PMID: 34671403 DOI: 10.1155/2021/1173324] [Reference Citation Analysis]
9 Shi B, Zhang RR, Liang Y, Wang XH, Lang R, Yu RH. Efficacy of Traditional Chinese Medicine Regimen Jian Pi Qu Shi Formula for Refractory Patients with Idiopathic Membranous Nephropathy: A Retrospective Case-Series Study. Evid Based Complement Alternat Med 2018;2018:5854710. [PMID: 30344612 DOI: 10.1155/2018/5854710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Chung C, Wu C, Hu W, Shih C, Liao Y, Hung Y. Tongue Diagnosis Index of Chronic Kidney Disease. Biomedical Journal 2022. [DOI: 10.1016/j.bj.2022.02.001] [Reference Citation Analysis]
11 Fang J, Wang W, Sun S, Wang Y, Li Q, Lu X, Qiu M, Zhang Y. Metabolomics study of renal fibrosis and intervention effects of total aglycone extracts of Scutellaria baicalensis in unilateral ureteral obstruction rats. Journal of Ethnopharmacology 2016;192:20-9. [DOI: 10.1016/j.jep.2016.06.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
12 Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial. Trials 2017;18:170. [PMID: 28395659 DOI: 10.1186/s13063-016-1774-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yang L, Wang M, Zhou Y, Yang J, Ye C, Wang C. Shen Shuai II Recipe Attenuates Renal Interstitial Fibrosis by Improving Hypoxia via the IL-1β/c-Myc Pathway. Evid Based Complement Alternat Med 2021;2021:5539584. [PMID: 34211565 DOI: 10.1155/2021/5539584] [Reference Citation Analysis]
14 Wang Y, Liu T, Ma F, Lu X, Mao H, Zhou W, Yang L, Li P, Zhan Y. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease. J Diabetes Res 2020;2020:2421631. [PMID: 33274236 DOI: 10.1155/2020/2421631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Liu M, Gao Y, Yuan Y, Yang K, Shi S, Zhang J, Tian J. Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res. 2020;158:104896. [PMID: 32438037 DOI: 10.1016/j.phrs.2020.104896] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 28.0] [Reference Citation Analysis]
16 Guo Y, Liu F, Chen M, Tian Q, Tian X, Xiong Q, Huang C. Huangjinsan ameliorates adenine-induced chronic kidney disease by regulating metabolic profiling. J Sep Sci 2021;44:4384-94. [PMID: 34688222 DOI: 10.1002/jssc.202100542] [Reference Citation Analysis]
17 Li S, Li JP. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial. Trials 2020;21:31. [PMID: 31907076 DOI: 10.1186/s13063-019-3989-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Huang TI, Hsieh CL. Effect of Traditional Chinese Medicine on Long-Term Outcomes of Snakebite in Taiwan. Toxins (Basel) 2020;12:E132. [PMID: 32093388 DOI: 10.3390/toxins12020132] [Reference Citation Analysis]
19 Xu L, Hu J, Liu L, Zhan S, Wang S. Trends and Patterns in Traditional Chinese Medicine Use Among Chinese Population in Late Adulthood: An Eight-Year Repeated Panel Survey. Am J Chin Med 2021;49:269-83. [PMID: 33622208 DOI: 10.1142/S0192415X21500142] [Reference Citation Analysis]
20 Yuan D, Yang X, Guo JC. A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine. J Zhejiang Univ Sci B 2016;17:405-8. [PMID: 27143269 DOI: 10.1631/jzus.B1600094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
21 Liu B, He Y, Lu R, Zhou J, Bai L, Zhang P, Ye S, Wu J, Liang C, Zhou Y, Zhou J. Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway. Biomed Pharmacother 2018;101:635-47. [PMID: 29518610 DOI: 10.1016/j.biopha.2018.02.127] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
22 Xia H, Zhang B, Yang D, Zhu C, Zhang J, Chen H, Ma H, Hu S, Xu C, Shi C, Lu K, Zhang P. Yi-Qi-Jian-Pi-Xiao-Yu-Xie-Zhuo Formula Improves Muscle Atrophy via Modulating the IGF-1/PI3K/Akt Signaling Pathway in 5/6 Nephrectomized Rats. Front Pharmacol 2021;12:624303. [PMID: 33986663 DOI: 10.3389/fphar.2021.624303] [Reference Citation Analysis]
23 Jia MQ, Xiong YJ, Xue Y, Wang Y, Yan C. Using UPLC-MS/MS for Characterization of Active Components in Extracts of Yupingfeng and Application to a Comparative Pharmacokinetic Study in Rat Plasma after Oral Administration. Molecules 2017;22:E810. [PMID: 28513568 DOI: 10.3390/molecules22050810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
24 Khan MA, Kassianos AJ, Hoy WE, Alam AK, Healy HG, Gobe GC. Promoting Plant-Based Therapies for Chronic Kidney Disease. J Evid Based Integr Med 2022;27:2515690X221079688. [PMID: 35243916 DOI: 10.1177/2515690X221079688] [Reference Citation Analysis]
25 Zhong Y, Lee K, Deng Y, Ma Y, Chen Y, Li X, Wei C, Yang S, Wang T, Wong NJ, Muwonge AN, Azeloglu EU, Zhang W, Das B, He JC, Liu R. Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes. Nat Commun 2019;10:4523. [PMID: 31586053 DOI: 10.1038/s41467-019-12433-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
26 Chen D, Hu H, Wang Y, Feng Y, Cao G, Zhao Y. Natural products for the prevention and treatment of kidney disease. Phytomedicine 2018;50:50-60. [DOI: 10.1016/j.phymed.2018.09.182] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 12.8] [Reference Citation Analysis]
27 Liu X, Chen J, Liu X, Wang D, Zheng P, Qi A, Yi T, Li S. Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network. BMC Complement Altern Med 2018;18:340. [PMID: 30572886 DOI: 10.1186/s12906-018-2395-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
28 Dou F, Miao H, Wang JW, Chen L, Wang M, Chen H, Wen AD, Zhao YY. An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease. Front Pharmacol 2018;9:53. [PMID: 29472858 DOI: 10.3389/fphar.2018.00053] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
29 Lu J, Liu X, Liao Y, Wang D, Chen J, Li S. Jian-Pi-Yi-Shen Formula Regulates Inflammatory Cytokines Production in 5/6 Nephrectomized Rats via Suppression of NF-κB Activation. Evid Based Complement Alternat Med 2018;2018:7203547. [PMID: 30108662 DOI: 10.1155/2018/7203547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhu Y, Huang G, Yang Y, Yong C, Yu X, Wang G, Yi L, Gao K, Tian F, Qian S, Zhou E, Zou Y. Chinese Herbal Medicine Suyin Detoxification Granule Inhibits Pyroptosis and Epithelial-Mesenchymal Transition by Downregulating MAVS/NLRP3 to Alleviate Renal Injury. J Inflamm Res 2021;14:6601-18. [PMID: 34908861 DOI: 10.2147/JIR.S341598] [Reference Citation Analysis]
31 Liu B, Lu R, Li H, Zhou Y, Zhang P, Bai L, Chen D, Chen J, Li J, Yu P, Wu J, Liang C, Song J, Liu X, Zhou J. Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome. Phytomedicine 2019;59:152913. [PMID: 30991182 DOI: 10.1016/j.phymed.2019.152913] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
32 Zhang YY, Chen YL, Yi L, Gao K. IgA nephropathy treatment with traditional Chinese medicine: A case report. World J Clin Cases 2022; 10(10): 3232-3240 [DOI: 10.12998/wjcc.v10.i10.3232] [Reference Citation Analysis]
33 Feng Z, Liu W, Jiang HX, Dai H, Gao C, Dong Z, Gao Y, Liu F, Zhang Z, Zhao Q, Zhang L, Liu B. How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy? Front Pharmacol 2020;11:994. [PMID: 32719601 DOI: 10.3389/fphar.2020.00994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Li Q, Xing C, Yuan Y. Mitochondrial Targeting of Herbal Medicine in Chronic Kidney Disease. Front Pharmacol 2021;12:632388. [PMID: 34122064 DOI: 10.3389/fphar.2021.632388] [Reference Citation Analysis]
35 Wang Y, Zhao H, Wang Q, Zhou X, Lu X, Liu T, Zhan Y, Li P. Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy. J Diabetes Res 2019;2019:9030893. [PMID: 31828168 DOI: 10.1155/2019/9030893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Wang XT, Sun XJ, Li C, Liu Y, Zhang L, Li YD, Wu QH, Li SY, Li Y. Establishing a Cell-Based High-Content Screening Assay for TCM Compounds with Anti-Renal Fibrosis Effects. Evid Based Complement Alternat Med 2018;2018:7942614. [PMID: 30050593 DOI: 10.1155/2018/7942614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
37 Tan L, Deng X, Lai X, Zeng T, Li A, Hu J, Xiong Z. Mesoscale nanoparticles encapsulated with emodin for targeting antifibrosis in animal models. Open Chemistry 2020;18:1207-16. [DOI: 10.1515/chem-2020-0163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Wang M, Chen DQ, Chen L, Cao G, Zhao H, Liu D, Vaziri ND, Guo Y, Zhao YY. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. Br J Pharmacol 2018;175:2689-708. [PMID: 29679507 DOI: 10.1111/bph.14333] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 20.5] [Reference Citation Analysis]
39 Jiandong L, Yang Y, Peng J, Xiang M, Wang D, Xiong G, Li S. Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage. Biomed Pharmacother. 2019;109:93-102. [PMID: 30396096 DOI: 10.1016/j.biopha.2018.10.060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
40 Liu BH, Tu Y, Ni GX, Yan J, Yue L, Li ZL, Wu JJ, Cao YT, Wan ZY, Sun W, Wan YG. Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling. Front Pharmacol 2021;12:667644. [PMID: 34335245 DOI: 10.3389/fphar.2021.667644] [Reference Citation Analysis]
41 Li P, Lin H, Ni Z, Zhan Y, He Y, Yang H, Fang J, Wang N, Li W, Cai G, Chen Y, Zhang P, Wang X, Chen Q, Li Z, Sun X, Chen X. Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial. Phytomedicine 2020;76:153231. [PMID: 32535481 DOI: 10.1016/j.phymed.2020.153231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Chen YC, Chen HT, Yeh CC, Hung SK, Yu BH. Four prescribed Chinese herbal medicines provide renoprotection and survival benefit without hyperkalemia risk in patients with advanced chronic kidney disease: A nationwide cohort study. Phytomedicine 2021;95:153873. [PMID: 34896898 DOI: 10.1016/j.phymed.2021.153873] [Reference Citation Analysis]
43 Kolangi F, Shafi H, Memariani Z, Kamalinejad M, Bioos S, Jorsaraei SGA, Bijani A, Shirafkan H, Mozaffarpur SA. Effect of Alpinia officinarum Hance rhizome extract on spermatogram factors in men with idiopathic infertility: A prospective double-blinded randomised clinical trial. Andrologia 2019;51:e13172. [DOI: 10.1111/and.13172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Liu X, Huang S, Wang F, Zheng L, Lu J, Chen J, Li S. Huangqi-Danshen Decoction Ameliorates Adenine-Induced Chronic Kidney Disease by Modulating Mitochondrial Dynamics. Evid Based Complement Alternat Med 2019;2019:9574045. [PMID: 30713579 DOI: 10.1155/2019/9574045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang Y, Zhang L, Jin H, Wang D. Based on HIF-1α/Wnt/β-Catenin Pathway to Explore the Effect of Qingshen Granules on Chronic Renal Failure Patients: A Randomized Controlled Trial. Evid Based Complement Alternat Med 2019;2019:7656105. [PMID: 31354858 DOI: 10.1155/2019/7656105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
46 Chang T, Wang Y, Wang H, Jin D, Ma J, Zhang S, Thabane L. Comparative efficacy and safety of traditional Chinese medicine for IgA nephropathy: A systematic review and meta-analysis. European Journal of Integrative Medicine 2021;46:101372. [DOI: 10.1016/j.eujim.2021.101372] [Reference Citation Analysis]
47 Liu X, Zhang B, Huang S, Wang F, Zheng L, Lu J, Zeng Y, Chen J, Li S. Metabolomics Analysis Reveals the Protection Mechanism of Huangqi-Danshen Decoction on Adenine-Induced Chronic Kidney Disease in Rats. Front Pharmacol 2019;10:992. [PMID: 31551789 DOI: 10.3389/fphar.2019.00992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Zhang CY, Zhu JY, Ye Y, Zhang M, Zhang LJ, Wang SJ, Song YN, Zhang H. Erhuang Formula ameliorates renal damage in adenine-induced chronic renal failure rats via inhibiting inflammatory and fibrotic responses. Biomed Pharmacother 2017;95:520-8. [PMID: 28866419 DOI: 10.1016/j.biopha.2017.08.115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
49 Li N, Tang H, Wu L, Ge H, Wang Y, Yu H, Zhang X, Ma J, Gu HF. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases. Phytother Res 2021;35:198-206. [PMID: 32716080 DOI: 10.1002/ptr.6818] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
50 Gobe GC, Shen K. Chinese herbal medicines and chronic kidney disease: a positive outcome in a large patient study in Taiwan. Kidney Int 2015;88:1223-6. [PMID: 26649659 DOI: 10.1038/ki.2015.300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
51 Yang Y, Wei J, Huang X, Wu M, Lv Z, Tong P, Chang R. iTRAQ-Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha-1-Antitrypsin as Potential Biomarkers. Evid Based Complement Alternat Med 2017;2017:1480514. [PMID: 28536642 DOI: 10.1155/2017/1480514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
52 Stanifer JW, Kilonzo K, Wang D, Su G, Mao W, Zhang L, Zhang, Nayak-Rao S, Miranda JJ. Traditional Medicines and Kidney Disease in Low- and Middle-Income Countries: Opportunities and Challenges. Semin Nephrol 2017;37:245-59. [PMID: 28532554 DOI: 10.1016/j.semnephrol.2017.02.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
53 Liang B, Zhu YC, Lu J, Gu N. Effects of Traditional Chinese Medication-Based Bioactive Compounds on Cellular and Molecular Mechanisms of Oxidative Stress. Oxid Med Cell Longev 2021;2021:3617498. [PMID: 34093958 DOI: 10.1155/2021/3617498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Shi L, Feng L, Zhang M, Li X, Yang Y, Zhang Y, Ni Q. Abelmoschus manihot for Diabetic Nephropathy: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2019;2019:9679234. [PMID: 31118973 DOI: 10.1155/2019/9679234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
55 Wang D, Chen J, Liu X, Zheng P, Song G, Yi T, Li S. A Chinese herbal formula, Jian-Pi-Yi-Shen decoction, improves muscle atrophy via regulating mitochondrial quality control process in 5/6 nephrectomised rats. Sci Rep 2017;7:9253. [PMID: 28835671 DOI: 10.1038/s41598-017-10027-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
56 Rui-Zhi T, Hui D, Jian-Chun L, Xia Z, Xiao-Jia W, Dan W, Jun-Ming F, Li W. Astragalus mongholicus Bunge and Panax Notoginseng Formula (A&P) Combined With Bifidobacterium Contribute a Renoprotective Effect in Chronic Kidney Disease Through Inhibiting Macrophage Inflammatory Response in Kidney and Intestine. Front Physiol 2020;11:583668. [PMID: 33329031 DOI: 10.3389/fphys.2020.583668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Zhao J, Liu Z. Treatment of nephrotic syndrome: going beyond immunosuppressive therapy. Pediatr Nephrol 2020;35:569-79. [PMID: 30904930 DOI: 10.1007/s00467-019-04225-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Liu X, Deng R, Wei X, Wang Y, Weng J, Lao Y, Lu J, Xiong G, Li S. Jian-Pi-Yi-Shen formula enhances perindopril inhibition of chronic kidney disease progression by activation of SIRT3, modulation of mitochondrial dynamics, and antioxidant effects. Biosci Rep 2021;41:BSR20211598. [PMID: 34633033 DOI: 10.1042/BSR20211598] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Xie D, Li K, Ma T, Jiang H, Wang F, Huang M, Sheng Z, Xie Y. Therapeutic Effect and Safety of Tripterygium Glycosides Combined With Western Medicine on Type 2 Diabetic Kidney Disease: A Meta-Analysis. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2021.12.006] [Reference Citation Analysis]
60 Zha L, He L, Lian F, Zhen Z, Ji H, Xu L, Tong X. Clinical Strategy for Optimal Traditional Chinese Medicine (TCM) Herbal Dose Selection in Disease Therapeutics: Expert Consensus on Classic TCM Herbal Formula Dose Conversion. Am J Chin Med 2016;43:1515-24. [DOI: 10.1142/s0192415x1550086x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
61 Yu G, Guo M, Zou J, Zhou X, Ma Y. The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22181. [PMID: 32957343 DOI: 10.1097/MD.0000000000022181] [Reference Citation Analysis]